Wegovy

News

Novo Nordisk, Kry partner on digital programme for obesity

Digital health specialist Kry has teamed up with pharma group Novo Nordisk on the development of resources that can help people with obesity manage their condition and adhere to treatment.

News

Lilly fires a broadside at Novo Nordisk's obesity ambitions

Denmark's Novo Nordisk has been almost single-handedly rebuilding the market for drugs to treat obesity over the last few years with its GLP-1 agonist drugs

News

Novo Nordisk eyes obesity sales of $3.7bn in 2025 thanks to ...

Novo Nordisk's rollout of obesity therapy Wegovy has been beset by production problems, but the company says these are being resolved and it now anticipates it will help drive obesity sales

News

Novo Nordisk gets NICE okay for obesity drug Wegovy

Novo Nordisk's new obesity therapy Wegovy has been recommended for routine NHS use by UK cost-effectiveness watchdog NICE, but in a narrower group of patients than is covered by its MHRA-ap

News

Novo Nordisk nears EU approval of obesity drug Wegovy

Danish drugmaker Novo Nordisk is hoping to launch its once-weekly injectable treatment for obesity, Wegovy, in the EU next year after getting a green light from the EMA's human medicines co

News

FDA ends 7-year obesity drug drought, clearing Novo Nordisk'...

Novo Nordisk is celebrating the FDA approval of its GLP-1 agonist semaglutide as a treatment for obesity, which it believes has the potential to redefine the market for weight-loss medicine

Novo Nordisk, Kry partner on digital programme for obesity

Lilly fires a broadside at Novo Nordisk's obesity ambitions

Novo Nordisk eyes obesity sales of $3.7bn in 2025 thanks to ...

Novo Nordisk gets NICE okay for obesity drug Wegovy

Novo Nordisk nears EU approval of obesity drug Wegovy

FDA ends 7-year obesity drug drought, clearing Novo Nordisk'...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Wegovy

Editor's Picks